![Linagliptin diabetes drug molecule (dipeptidyl peptidase 4 or DPP4 inhibitor). Skeletal formula. Stock Vector | Adobe Stock Linagliptin diabetes drug molecule (dipeptidyl peptidase 4 or DPP4 inhibitor). Skeletal formula. Stock Vector | Adobe Stock](https://as2.ftcdn.net/v2/jpg/01/79/18/61/1000_F_179186154_SWUqYtlldHSMwEoBaTZF3lsnz7avuQHC.jpg)
Linagliptin diabetes drug molecule (dipeptidyl peptidase 4 or DPP4 inhibitor). Skeletal formula. Stock Vector | Adobe Stock
![PDF) Double Edge Effect of DPP4 Inhibitor Sitagliptin, A Type-2 Anti-Diabetic Drug, on Inflammation, Injury and Cancer PDF) Double Edge Effect of DPP4 Inhibitor Sitagliptin, A Type-2 Anti-Diabetic Drug, on Inflammation, Injury and Cancer](https://www.researchgate.net/profile/Biplab-Giri/publication/305681763/figure/fig1/AS:388541419933696@1469646901021/Depicting-various-roles-played-by-a-DPP-4-inhibitor-sitagliptin-in-sustaining-glycaemic_Q320.jpg)
PDF) Double Edge Effect of DPP4 Inhibitor Sitagliptin, A Type-2 Anti-Diabetic Drug, on Inflammation, Injury and Cancer
![Mechanism of action for GIP, GLP-1 analogues and DPP4 inhibitors in... | Download Scientific Diagram Mechanism of action for GIP, GLP-1 analogues and DPP4 inhibitors in... | Download Scientific Diagram](https://www.researchgate.net/profile/Sridhara-Janardhan-3/publication/260680847/figure/fig3/AS:513088665001985@1499341278619/Fig-3-Mechanism-of-action-for-GIP-GLP-1-analogues-and-DPP4-inhibitors-in-controlling.png)
Mechanism of action for GIP, GLP-1 analogues and DPP4 inhibitors in... | Download Scientific Diagram
![Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41574-020-0399-8/MediaObjects/41574_2020_399_Fig2_HTML.png)
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
![DPP-4 active site with active-site residues The catalytic pocket of... | Download Scientific Diagram DPP-4 active site with active-site residues The catalytic pocket of... | Download Scientific Diagram](https://www.researchgate.net/profile/Mark-Gorrell/publication/26837594/figure/fig3/AS:394221065392140@1471001034919/DPP-4-active-site-with-active-site-residues-The-catalytic-pocket-of-DPP-4-is-shown.png)
DPP-4 active site with active-site residues The catalytic pocket of... | Download Scientific Diagram
![Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41574-020-0399-8/MediaObjects/41574_2020_399_Fig1_HTML.png)
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
![Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications | JACC: Heart Failure Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications | JACC: Heart Failure](https://www.jacc.org/cms/asset/dde58cec-032b-4162-b0e3-6d58b996bac6/fx1.jpg)
Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications | JACC: Heart Failure
![Mechanism by which dipeptidyl peptidase-4 inhibitors increase the risk of heart failure and possible differences in heart failure risk - Journal of Cardiology Mechanism by which dipeptidyl peptidase-4 inhibitors increase the risk of heart failure and possible differences in heart failure risk - Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/53a6d589-1a7f-4456-98e1-394b3a05ca06/gr1_lrg.jpg)
Mechanism by which dipeptidyl peptidase-4 inhibitors increase the risk of heart failure and possible differences in heart failure risk - Journal of Cardiology
![DPP-4 inhibitors and venous thromboembolism: an analysis of the WHO spontaneous reporting database - The Lancet Diabetes & Endocrinology DPP-4 inhibitors and venous thromboembolism: an analysis of the WHO spontaneous reporting database - The Lancet Diabetes & Endocrinology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/147978a2-2524-49a2-8fd1-023ac0a870dc/gr1.gif)